Vascular Effects of High-Salt After Preeclampsia (NCT06749418)
Role of the Mineralocorticoid Receptor in Microvascular Endothelial Dysfunction After Preeclampsia
๐ฉบ Plain-English Summary (8th-Grade Level)
Women who develop preeclampsia during pregnancy are more likely to develop and die of cardiovascular disease later in life, even if they are otherwise healthy. Importantly, women who had preeclampsia have an exaggerated vascular responsiveness to hypertensive stimuli, such as high-salt intake, compared to women who had a healthy pregnancy. The reason why this occurs is unclear but may be related to impaired endothelial function and dysregulation of the angiotensin system that occurs during the preeclamptic pregnancy and persists postpartum, despite the remission of clinical symptoms. While the association between a history of preeclampsia and vascular dysfunction leading to elevated CVD risk is well known, the mechanisms underlying this dysfunction remains unclear. The purpose of this study is to examine the role of vascular mineralocorticoid receptor, the terminal receptor in the angiotensin system that contributes to blood pressure regulation, in mediating exaggerated microvascular endothelial dysfunction before and after a high-salt stimulus. This will help us better understand the mechanisms of microvascular dysfunction these women, and how inhibition of these receptors may improve microvascular function. In this study, we use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) we examine the blood vessels in a nickel-sized area of the skin.
Who can join: Review the eligibility criteria below.
Location: University of Iowa โ Iowa City, Iowa
Age range: 18 Years to 45 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- University of Iowa โ Iowa City, Iowa
๐ Contact the Study Coordinator
Phone: (319) 467-1732
Email: kelsey-schwartz@uiowa.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Preeclampsia
- Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial โ Pittsburgh, Pennsylvania
- Preeclampsia Postpartum Antihypertensive Treatment โ Milwaukee, Wisconsin
- Preeclampsia Educational Program Study (PrEPS) โ Long Beach, California
- Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients โ Charlottesville, Virginia
- MR and Inflammation After Preeclampsia โ Iowa City, Iowa
- Clinician Notification to Increase Aspirin Prophylaxis for Preeclampsia Prevention โ Boston, Massachusetts
Explore by condition: All Preeclampsia clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.